Avicanna Inc. (AVCNF) Financials

AVCNF Assets vs Liabilities

DateAssetsLiabilities
Sept. 30, 2026 16.5 million 6.2 million
June 30, 2026 17.0 million 7.1 million
March 31, 2026 15.9 million 6.7 million
Dec. 31, 2025 15.5 million 7.2 million

AVCNF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 -498406 ?
June 30, 2026 -935161 ?
March 31, 2026 -696936 49297
Dec. 31, 2025 -144980 259384

AVCNF Net Income

No data available :(

AVCNF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 106600 - -
June 30, 2026 141121 - -
March 31, 2026 267531 - -
Dec. 31, 2025 204524 - -

AVCNF Shares Outstanding

No data available :(

AVCNF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 4395 11817 2.0 million -
June 30, 2026 115009 8889 2.9 million 326263
March 31, 2026 9337 11498 2.9 million 687326
Dec. 31, 2025 5739 41335 3.0 million 725197

AVCNF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 3.9 million 1.8 million
June 30, 2026 4.0 million 1.9 million
March 31, 2026 4.8 million 2.3 million
Dec. 31, 2025 4.8 million 2.3 million

AVCNF

Price: $0.06

52 week price:
0.06
0.22

Earnings Per Share: -0.02 USD

P/E Ratio: -6.85

Exchange: OQX

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 8.9 million

Links: